Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank67
3Y CAGR-65.2%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-65.2%/yr
Quarterly compound
Percentile
P67
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.91% |
| Q3 2025 | -0.27% |
| Q2 2025 | -6.13% |
| Q1 2025 | 6.19% |
| Q4 2024 | -8.14% |
| Q3 2024 | 2.78% |
| Q2 2024 | 10.86% |
| Q1 2024 | 11.47% |
| Q4 2023 | -8.44% |
| Q3 2023 | 12.55% |
| Q2 2023 | -8.18% |
| Q1 2023 | 24.22% |
| Q4 2022 | 21.63% |
| Q3 2022 | -10.63% |
| Q2 2022 | -12.89% |
| Q1 2022 | -9.79% |
| Q4 2021 | -6.21% |
| Q3 2021 | -2.81% |
| Q2 2021 | 13.62% |
| Q1 2021 | -2.33% |
| Q4 2020 | -1.77% |
| Q3 2020 | -4.31% |
| Q2 2020 | 183.58% |
| Q1 2020 | -16.35% |
| Q4 2019 | -12.91% |
| Q3 2019 | -9.22% |
| Q2 2019 | -5.54% |
| Q1 2019 | -4.02% |
| Q4 2018 | 77.53% |
| Q3 2018 | -4.89% |
| Q2 2018 | -7.32% |
| Q1 2018 | 97.75% |
| Q4 2017 | -10.69% |
| Q3 2017 | 26.05% |
| Q2 2017 | -11.18% |
| Q1 2017 | -9.60% |
| Q4 2016 | -5.73% |
| Q3 2016 | -5.80% |
| Q2 2016 | 92.07% |
| Q1 2016 | -4.62% |